Jaguar Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Jaguar Health Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- JAGX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001585608
Board of directors
-
Anula Jayasuriya · DirectorSince 2023
-
James J. Bochnowski · DirectorSince 2023
-
John Micek · DirectorSince 2023
-
Jonathan B. Siegel · DirectorSince 2023
-
Lisa A. Conte · Director · See RemarksSince 2023
Chief executives
Lisa A. Conte
· CEO and President
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Anula Jayasuriya
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Chaturvedi Pravin R Officer (Chief Scientific Officer) | Grant or award | +11,740 | — | — |
| Dec 11, 2025 | James J. Bochnowski Director | Grant or award | +6,363 | — | — |
| Dec 11, 2025 | Jonathan B. Siegel Director | Grant or award | +7,377 | — | — |
| Dec 11, 2025 | Anula Jayasuriya Director | Grant or award | +5,870 | — | — |
| Dec 11, 2025 | Lizak Carol R. Officer (Chief Financial Officer) | Grant or award | +11,740 | — | — |
| Dec 11, 2025 | John Micek Director | Grant or award | +7,377 | — | — |
| Dec 11, 2025 | King Steven R. Officer (See Remarks) | Grant or award | +11,740 | — | — |
| Dec 11, 2025 | Wolin Jonathan S. Officer (See Remarks) | Grant or award | +11,740 | — | — |
| Dec 11, 2025 | Lisa A. Conte Director, Officer (See Remarks) | Grant or award | +28,592 | — | — |
| May 17, 2025 | King Steven R. Officer (See Remarks) | Option exercise | +1 | — | — |
| May 17, 2025 | Lisa A. Conte Director, Officer (CEO and President) | Option exercise | +2 | — | — |
| Oct 8, 2024 | Lizak Carol R. Officer (Chief Financial Officer) | Grant or award | +4,280 | — | — |
| Oct 8, 2024 | Chaturvedi Pravin R Officer (Chief Scientific Officer) | Grant or award | +4,922 | — | — |
| Oct 8, 2024 | Wolin Jonathan S. Officer (See Remarks) | Grant or award | +4,922 | — | — |
| Oct 8, 2024 | Lisa A. Conte Director, Officer (See Remarks) | Grant or award | +16,503 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.